Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)

NCT01462370 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysmenorrhea

Interventions

DRUG: Etoricoxib
DRUG: Ibuprofen
DRUG: Placebo to etoricoxib
DRUG: Placebo to ibuprofen
DRUG: Acetaminophen 250 mg, isopropylantipyrine 150 mg and anhydrous caffeine 50 mg

Sponsor

Organon and Co